Newsbenzinga
Medtronic Unleashes $780 Million Deal Spree After Strong Quarter
· Published
Article summary
Medtronic (NYSE: MDT) stock rose after beating Q1 estimates and raising its FY27 forecast on strong cardiovascular sales.
An excerpt from the original article.
Comments —
Loading comments…